Reticulocyte hemoglobin content in hemodialysis patients with acute infection

Clinical and Experimental Nephrology

Volumn 8, Issue 3, 2004, Pages 257-262

  Mitsuiki, Koji ^a   Harada, Atsumi ^a   Miyata, Yasuji ^a  

^a MATSUYAMA RED CROSS HOSPITAL   (Japan)

Author keywords

Acute infection; C reactive protein; Erythropoietin; Functional iron deficiency; Reticulocyte hemoglobin content

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; FERRITIN; HEMOGLOBIN; IRON; RECOMBINANT ERYTHROPOIETIN; TRANSFERRIN;

AGED; ARTICLE; CLINICAL ARTICLE; DOSE RESPONSE; ERYTHROPOIESIS; FEMALE; FERRITIN BLOOD LEVEL; HEMATOCRIT; HEMODIALYSIS; HEMOGLOBIN DETERMINATION; HUMAN; INFLAMMATORY DISEASE; IRON STORAGE; IRON THERAPY; MALE; RESPIRATORY TRACT INFECTION; RETICULOCYTE; RETROSPECTIVE STUDY;

ACUTE DISEASE; AGED; C-REACTIVE PROTEIN; ERYTHROPOIETIN, RECOMBINANT; FEMALE; FERRITINS; HEMATOCRIT; HEMOGLOBINS; HUMANS; IRON; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; RESPIRATORY TRACT INFECTIONS; RETICULOCYTES; RETROSPECTIVE STUDIES; TRANSFERRIN;

EID: 7044239536     PISSN: 13421751     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10157-004-0295-x     Document Type: Article

References (21)

1. Sunder-Plassmann G, Hörl WH. Importance of iron supply for erythropoietin therapy. Nephrol Dial Transplant 1995; 10: 2070-6.
2. Mitsuiki K, Harada A, Miyata Y. Reduction of recombinant human erythropoietin maintenance dose by supplementation with a low-dose iron preparation, given intravenously. Clin Exp Nephrol 2001; 5: 228-33.
3. National Kidney Foundation. DOQI (Dialysis Outcomes Quality Initiative) Clinical practice guidelines for the treatment of anemia of chronic renal failure. Am J Kidney Dis 1997; 30 (Suppl 3): S192-S240.
4. Nissenson AR. Achieving target hematocrit in dialysis patients: new concepts in iron management. Am J Kidney Dis 1997; 30: 907-11.
5. Fishbane S, Galgano C, Langley RC Jr, Canfield W, Maesaka JK. Reticulocyte hemoglobin content in the evaluation of iron status of hemodialysis patients. Kidney Int 1997; 52: 217-22.
6. Mittman N, Sreedhara R, Mushnick R, Chattopadhyay J, Zelmanovic D, Vaseghi M, et al. Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO. Am J Kidney Dis 1997; 30: 912-22.
7. Cullen P, Söffker J, Höpfl M, Bremer C, Schlaghecken R, Mehrens T, et al. Hypochromic red cells and reticulocyte haemoglobin content as markers of iron-deficient erythropoiesis in patients undergoing chronic haemodialysis. Nephrol Dial Transplant 1999; 14: 659-65.
8. Statland BE, Winkel P, Bokelund H. Variation of serum iron concentration in young healthy men: within-day and day-to-day changes. Clin Biochem 1976; 9: 26-9.
9. Weiss G, Widner B, Zoller H, Schobersberger W, Fuchs D. Immune response and iron metabolism. Br J Anaesth 1998; 81 (Suppl 1): 6-9.
10. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448-54.
11. Macdougall IC, Cavill I, Hulme B, Bain B, McGregor E, McKay P, et al. Detection of functional iron deficiency during erythropoietin treatment: a new approach. BMJ 1992; 304: 225-6.
12. Beguin BY, Loo M, R'Zik S, Sautois B, Lejeune F, Rorive G, et al. Early prediction of response to recombinant human erythropoietin in patients with the anemia of renal failure by serum transferring receptor and fibrinogen. Blood 1993; 82: 2010-16.
13. Fishbane S, Shapiro W, Dutka P, Valenzuela OF, Faubert J. A randomized trial of iron deficiency testing strategies in hemodialysis patients. Kidney Int 2001; 60: 2406-11.
14. Kaneko Y, Miyazaki S, Hirasawa Y, Gejyo F, Suzuki M. Transferrin saturation versus reticulocyte hemoglobin content for iron deficiency in Japanese hemodialysis patients. Kidney Int 2003; 63: 1086-93.
15. Mitsuiki K, Harada A, Miyata Y. Assessment of iron deficiency in chronic hemodialysis patients: investigation of cutoff values for reticulocyte hemoglobin content. Clin Exp Nephrol 2003; 7: 52-7.
16. Macdougall IC. Poor response to erythropoietin: practical guidelines on investigation and management. Nephrol Dial Transplant 1995; 10: 607-14.
17. Drüeke T. Hyporesponsiveness to recombinant human erythropoietin. Nephrol Dial Transplant 2001; 16 (Suppl 7): 25-8.
18. Macdougall IC, Cooper AC. Erythropoietin resistance: the role of inflammation and pro-inflammatory cytokines. Nephrol Dial Transplant 2002; 17 (Suppl 11): 39-43.
19. Bárány P, Fiho JCD, Bergström J. High C-reactive protein is a strong predictor of resistance to erythropoietin in hemodialysis patients. Am J Kidney Dis 1997; 29: 565-8.
20. Eskeland B, Baerheim A, Ulvik R, Hunskaar S. Influence of mild infections on iron status parameters in women of reproductive age. Scand J Prim Health Care 2002; 20: 50-6.
21. Kooistra MP, Niemantsverdriet EC, Van Es A, Mol-Beermann NM, Struyvenberg A, Marx JJM. Iron absorption in erythropoietin-treated haemodialysis patients: effects of iron availability, inflammation and aluminium. Nephrol Dial Transplant 1998; 13: 82-8.